Filing Details

Accession Number:
0001104659-21-052071
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-19 18:35:59
Reporting Period:
2021-04-15
Accepted Time:
2021-04-19 18:35:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1737953 Replimune Group Inc. REPL () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1376493 Colin Love C/O Replimune Group, Inc.
500 Unicorn Park
Woburn MA 01801
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-04-15 27,300 $30.69 898,509 No 4 S Direct
Common Stock Disposition 2021-04-15 2,700 $29.98 895,809 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
  2. The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.22 to $31.19. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.76 to $30.17. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  4. Following the sales reported on this Form 4, the reporting person continues to beneficially own 895,809 shares of the Issuer's common stock. The reporting person also holds options to acquire 503,578 shares of the Issuer's common stock, 274,077 of which are exercisable as of the date hereof.